Cargando…

Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013

Objective. Compare glaucoma medication costs between the United States (USA) and Canada. Methods. We modelled glaucoma brand name and generic medication annual costs in the USA and Canada based on October 2013 Costco prices and previously reported bottle overfill rates, drops per mL, and wastage adj...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlenker, Matthew B., Trope, Graham E., Buys, Yvonne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397467/
https://www.ncbi.nlm.nih.gov/pubmed/25922760
http://dx.doi.org/10.1155/2015/547960
_version_ 1782366706482544640
author Schlenker, Matthew B.
Trope, Graham E.
Buys, Yvonne M.
author_facet Schlenker, Matthew B.
Trope, Graham E.
Buys, Yvonne M.
author_sort Schlenker, Matthew B.
collection PubMed
description Objective. Compare glaucoma medication costs between the United States (USA) and Canada. Methods. We modelled glaucoma brand name and generic medication annual costs in the USA and Canada based on October 2013 Costco prices and previously reported bottle overfill rates, drops per mL, and wastage adjustment. We also calculated real wholesale price changes from 2006 to 2013 based on the Average Wholesale Price (USA) and the Ontario Drug Benefit Price (Canada). Results. US brand name medication costs were on average 4x more than Canadian medication costs (range: 1.9x–6.9x), averaging a cost difference of $859 annually. US generic costs were on average the same as Canadian costs, though variation exists. US brand name wholesale prices increased from 2006 to 2013 more than Canadian prices (US range: 29%–349%; Canadian range: 9%–16%). US generic wholesale prices increased modestly (US range: −23%–58%), and Canadian wholesale prices decreased (Canadian range: −38%–0%). Conclusions. US brand name glaucoma medications are more expensive than Canadian medications, though generic costs are similar (with some variation). The real prices of brand name medications increased more in the USA than in Canada. Generic price changes were more modest, with real prices actually decreasing in Canada.
format Online
Article
Text
id pubmed-4397467
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-43974672015-04-28 Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013 Schlenker, Matthew B. Trope, Graham E. Buys, Yvonne M. J Ophthalmol Research Article Objective. Compare glaucoma medication costs between the United States (USA) and Canada. Methods. We modelled glaucoma brand name and generic medication annual costs in the USA and Canada based on October 2013 Costco prices and previously reported bottle overfill rates, drops per mL, and wastage adjustment. We also calculated real wholesale price changes from 2006 to 2013 based on the Average Wholesale Price (USA) and the Ontario Drug Benefit Price (Canada). Results. US brand name medication costs were on average 4x more than Canadian medication costs (range: 1.9x–6.9x), averaging a cost difference of $859 annually. US generic costs were on average the same as Canadian costs, though variation exists. US brand name wholesale prices increased from 2006 to 2013 more than Canadian prices (US range: 29%–349%; Canadian range: 9%–16%). US generic wholesale prices increased modestly (US range: −23%–58%), and Canadian wholesale prices decreased (Canadian range: −38%–0%). Conclusions. US brand name glaucoma medications are more expensive than Canadian medications, though generic costs are similar (with some variation). The real prices of brand name medications increased more in the USA than in Canada. Generic price changes were more modest, with real prices actually decreasing in Canada. Hindawi Publishing Corporation 2015 2015-04-01 /pmc/articles/PMC4397467/ /pubmed/25922760 http://dx.doi.org/10.1155/2015/547960 Text en Copyright © 2015 Matthew B. Schlenker et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Schlenker, Matthew B.
Trope, Graham E.
Buys, Yvonne M.
Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013
title Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013
title_full Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013
title_fullStr Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013
title_full_unstemmed Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013
title_short Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013
title_sort comparison of united states and canadian glaucoma medication costs and price change from 2006 to 2013
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397467/
https://www.ncbi.nlm.nih.gov/pubmed/25922760
http://dx.doi.org/10.1155/2015/547960
work_keys_str_mv AT schlenkermatthewb comparisonofunitedstatesandcanadianglaucomamedicationcostsandpricechangefrom2006to2013
AT tropegrahame comparisonofunitedstatesandcanadianglaucomamedicationcostsandpricechangefrom2006to2013
AT buysyvonnem comparisonofunitedstatesandcanadianglaucomamedicationcostsandpricechangefrom2006to2013